Search Within

GDMT, Medicine

Formats
  1. Journal Article (935)
  2. Meeting Abstract (836)
  3. Review (49)
  4. Book Section (38)
  5. Editorial (30)
  6. Guidelines (19)
  7. Correspondence (7)
  8. Research Letter (1)
Groups
  1. Gynecology Disease Management Team (1915)
  2. Department of Medicine (1904)
  3. Solid Tumor Oncology Division (1904)
  4. Gynecologic Medicine Service (1864)
  5. Surgery (585)
  6. GDMT, Surgery (467)

More Groups

People
  1. Carol Aghajanian (616)
  2. Martee Hensley (290)
  3. Nadeem Abu-Rustum (281)
  4. Roisin O'Cearbhaill (275)
  5. Vicky Makker (270)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (78)
  2. 2024 (159)
  3. 2023 (165)
  4. 2022 (196)
  5. 2021 (146)
  6. 2020 (173)

More Years

Publications
  1. Journal of Clinical Oncology (421)
  2. Gynecologic Oncology (419)
  3. International Journal of Gynecological Cancer (156)
  4. Annals of Oncology (107)
  5. Clinical Cancer Research (65)
  6. Cancer (37)

More Publications

Publishers
  1. American Society of Clinical Oncology (453)
  2. Elsevier B.V. (443)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (141)
  5. Oxford University Press (130)
  6. Elsevier Inc. (83)

More Publishers

Results (1915)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • My individualized risk reduction for ovarian cancer (MIRROR): Development of a patient decision aid for risk-reducing surgery in hereditary risk for ovarian cancer
    Meeting Abstract

    Feinberg, J.; Gordhandas, S.; Austria, M.; Carlsson, S.; Abu-Rustum, N.; Liu, Y.; Roche, K. L.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Leave it in the past: Primary treatment modality for high-grade epithelial ovarian cancer does not affect secondary cytoreduction outcomes
    Meeting Abstract

    Manning-Geist, B.; Sia, T.; Ehmann, S.; Luardo, C.; Praiss, A.; Lavery, J.; Iasonos, A.; Sonoda, Y.; Grisham, R.; Zivanovic, O.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Oncolytic immunotherapy with recombinant Newcastle disease virus-encoding interleukin-12 in ovarian cancer mouse models
    Meeting Abstract

    Kahn, R.; Green, H.; Pesci, G.; Burman, B.; Praiss, A.; Ozsoy, M.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; Chi, D.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Surgical stress promotes IL-6-driven tumor progression in ovarian cancer
    Meeting Abstract

    Praiss, A.; Longhini, A. L. F.; Pesci, G.; Green, H.; Ozsoy, M.; Kahn, R.; Brodeur, M.; Bhaloo, S.; Merghoub, T.; Wolchok, J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab versus placebo in addition to carboplatin and paclitaxel for measurable stage 3 or 4a, stage 4b or recurrent endometrial cancer: The phase 3, NRG GY018 study
    Meeting Abstract

    Eskander, R.; Sill, M.; Beffa, L.; Moore, R.; Hope, J.; Musa, F.; Mannel, R.; Shahin, M.; Cantuaria, G.; Girda, E.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma
    Meeting Abstract

    Liu, J.; Colombo, N.; Oza, A.; Frenel, J. S.; Corr, B.; Rubinstein, M.; Nevadunsky, N.; Lheureux, S.; Gaba, L.; Cortijo, L. G.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRĪ±) expression: Evaluation of sequence of therapy on anti-tumor activity in the SORAYA study
    Meeting Abstract

    Coleman, R.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; Harter, P.; Murphy, C.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Evolution of peripheral and tumor immune parameters as biomarkers of differential sequencing of immune checkpoint blockade and chemoradiotherapy in locally advanced cervical cancer: An NRG Oncology/GOG Study
    Meeting Abstract

    Zamarin, D.; Deng, W.; Lankes, H.; Ghamande, S.; Holman, L.; Mathews, C.; Park, K.; Banbury, B.; Sherry, N.; Kim, H.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Transforming ovarian cancer care by targeting minimal residual disease
    Editorial

    Jazaeri, A. A.; Grisham, R.; Knisely, A.; Spranger, S.; Zamarin, D.; Hillman, R. T.; Lawson, B. C.; Burns, K. H.; Lee, S.; Westin, S. N.; more...
    Med (2023)

    Fulltext@MSK | Save
  • Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement
    Review

    Girda, E.; Randall, L. M.; Chino, F.; Monk, B. J.; Farley, J. H.; O'Cearbhaill, R. E.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save